Kinnera S, Owasoyo O, Rahim H, Rahim A, Sunil K, Chaudhary P
Cureus. 2024; 16(11):e73967.
PMID: 39703298
PMC: 11656189.
DOI: 10.7759/cureus.73967.
Uehara Y, Tanaka Y, Zhao S, Nikolaidis N, Pitstick L, Wu H
Nat Commun. 2023; 14(1):1205.
PMID: 36864068
PMC: 9981730.
DOI: 10.1038/s41467-023-36810-8.
Wu K, Cao S, Weaver C, King N, Patel S, Kim T
J Clin Endocrinol Metab. 2022; 108(2):351-360.
PMID: 36196648
PMC: 10091486.
DOI: 10.1210/clinem/dgac579.
Hasan M, Oster M, Reyer H, Ponsuksili S, Murani E, Wolf P
Metabolites. 2022; 12(8).
PMID: 36005601
PMC: 9413461.
DOI: 10.3390/metabo12080729.
Young K, Beggs M, Grimbly C, Alexander R
Exp Biol Med (Maywood). 2022; 247(13):1103-1111.
PMID: 35482362
PMC: 9335508.
DOI: 10.1177/15353702221091982.
The Role of Diet in Bone and Mineral Metabolism and Secondary Hyperparathyroidism.
Bargagli M, Arena M, Naticchia A, Gambaro G, Mazzaferro S, Fuster D
Nutrients. 2021; 13(7).
PMID: 34371838
PMC: 8308808.
DOI: 10.3390/nu13072328.
24-Hydroxylase Deficiency Due to Sequence Variants: Comparison With Other Vitamin D-mediated Hypercalcemia Disorders.
Azer S, Vaughan L, Tebben P, Sas D
J Endocr Soc. 2021; 5(9):bvab119.
PMID: 34337279
PMC: 8317629.
DOI: 10.1210/jendso/bvab119.
Calcium-Sensing Receptors Control CYP27B1-Luciferase Expression: Transcriptional and Posttranscriptional Mechanisms.
Huang A, Binmahfouz L, Hancock D, Anderson P, Ward D, Conigrave A
J Endocr Soc. 2021; 5(9):bvab057.
PMID: 34337274
PMC: 8317635.
DOI: 10.1210/jendso/bvab057.
Hyperphosphatemia with elevated serum PTH and FGF23, reduced 1,25(OH)D and normal FGF7 concentrations characterize patients with CKD.
Kritmetapak K, Losbanos L, Berent T, Ashrafzadeh-Kian S, Algeciras-Schimnich A, Hines J
BMC Nephrol. 2021; 22(1):114.
PMID: 33784965
PMC: 8011073.
DOI: 10.1186/s12882-021-02311-3.
Sclerostin and Osteocalcin: Candidate Bone-Produced Hormones.
Wang J, Mazur C, Wein M
Front Endocrinol (Lausanne). 2021; 12:584147.
PMID: 33776907
PMC: 7988212.
DOI: 10.3389/fendo.2021.584147.
Changes in Salivary Analytes of Horses Due to Circadian Rhythm and Season: A Pilot Study.
Contreras-Aguilar M, Lamy E, Escribano D, Ceron J, Tecles F, Quiles A
Animals (Basel). 2020; 10(9).
PMID: 32846911
PMC: 7552333.
DOI: 10.3390/ani10091486.
Phosphate as a Signaling Molecule.
Kritmetapak K, Kumar R
Calcif Tissue Int. 2019; 108(1):16-31.
PMID: 31768576
PMC: 7246150.
DOI: 10.1007/s00223-019-00636-8.
Secondary and Tertiary Hyperparathyroidism in Chronic Kidney Disease: An Endocrine and Renal Perspective.
Chandran M, Wong J
Indian J Endocrinol Metab. 2019; 23(4):391-399.
PMID: 31741895
PMC: 6844175.
DOI: 10.4103/ijem.IJEM_292_19.
Urine albumin and serum uric acid are important determinants of serum 25 hydroxyvitamin D level in pre-dialysis chronic kidney disease patients.
Fayed A, El Nokeety M, Heikal A, Sadek K, Hammad H, Abdulazim D
Ren Fail. 2019; 41(1):540-546.
PMID: 31234687
PMC: 6598477.
DOI: 10.1080/0886022X.2018.1563552.
The Emerging Role of Nutritional Vitamin D in Secondary Hyperparathyroidism in CKD.
Lu C, Yeih D, Hou Y, Jow G, Li Z, Liu W
Nutrients. 2018; 10(12).
PMID: 30513912
PMC: 6316278.
DOI: 10.3390/nu10121890.
Physiologic and pathophysiologic roles of extra renal CYP27b1: Case report and review.
Bikle D, Patzek S, Wang Y
Bone Rep. 2018; 8:255-267.
PMID: 29963603
PMC: 6021194.
DOI: 10.1016/j.bonr.2018.02.004.
The Use of Vitamin D Metabolites and Analogues in the Treatment of Chronic Kidney Disease.
Zand L, Kumar R
Endocrinol Metab Clin North Am. 2017; 46(4):983-1007.
PMID: 29080646
PMC: 5977979.
DOI: 10.1016/j.ecl.2017.07.008.
Vitamin D and Hypertension.
Jeong H, Park K, Lee M, Yang D, Kim S, Lee S
Electrolyte Blood Press. 2017; 15(1):1-11.
PMID: 29042901
PMC: 5641496.
DOI: 10.5049/EBP.2017.15.1.1.
Vitamin D-Mediated Hypercalcemia: Mechanisms, Diagnosis, and Treatment.
Tebben P, Singh R, Kumar R
Endocr Rev. 2016; 37(5):521-547.
PMID: 27588937
PMC: 5045493.
DOI: 10.1210/er.2016-1070.
Vitamin D and chronic kidney disease.
Kim C, Kim S
Korean J Intern Med. 2014; 29(4):416-27.
PMID: 25045287
PMC: 4101586.
DOI: 10.3904/kjim.2014.29.4.416.
